All News #Library
Others
MAbxience Names New Chief Executive Officer
10 May 2024 //
CONTRACT PHARMA
MAbxience And Biosidus Sign CDMO Agreement For Fabry Disease Drug
05 Feb 2024 //
PRESS RELEASE
mAbxience Continues MCE with ABEC Single-Use Bioreactor Technology
02 Jun 2022 //
BUSINESSWIRE

Market Place
Sourcing Support